Page 10 - Anubhuti Mishra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

yatharth hospital trading strategy: Yatharth Hospital misses Street expectations on listing What should investors do now?

"Investors who are looking for short-term gains may book profits at this level. However, aggressive investors who believe in the long-term prospects of the company may hold the stock with a stop loss at around the issue price," said Anubhuti Mishra, Equity Research Analyst at Swastika Investmart.

Uttar pradeshAstha jainAnubhuti mishraYatharth hospital trauma care servicesTrauma centre in orchhaEquity research analyst at swastika investmartYatharth hospitalEquity research analystHem securitiesTrauma care servicesRamraja multispeciality hospitalTrauma centreYatharth hospital ipoYatharth hospital trading strategyYatharth hospital listingYatharth hospital share price

Yatharth Hospital shares: After a disappointing debut a D-St; is it time to buy the debutant?

Shares Yatharth Hospital saw some follow-up buying as the stock surged about 13 per cent to Rs 338.70 on Monday and the stock was hovering in the range of Rs 330-335.

Uttar pradeshMadhya pradeshAnubhuti mishraMaheshm ojhaEquity research analyst at swastika investmartNational stock exchangeTrauma care servicesResearch at hensex securitiesYatharth hospital trauma care servicesYatharth hospitalDalal streetEquity research analystGreater noidaYatharth hospital ipoYatharth hospitalAtharth hospital ipo listing price

Yatharth Hospital shares close with 11% premium on debut

The stock opened at Rs 306.10, which was also its day s low, a 2 percent premium over the issue price of Rs 300 per share, which was much lower than analysts expectations of at least a 20 percent listing premium

Anubhuti mishraUtkarsh small finance bankTrauma care serviceIdeaforge technologyYatharth hospitalSwastika investmartNetweb technologiesSenco goldMankind pharmaYatharth hospital share priceYatharth hospital stock priceYatharth hospital ipo price

SBFC Finance IPO versus Concord Biotech IPO: Which one should you choose?

SBFC Finance IPO and Concord Biotech IPO open for subscription, analysts bullish on both. Some experts have given preference to SBFC Finance IPO. Read on to know why:

Anubhuti mishraVaibhav kaushikVinit bolinjkarBanking financial companyEquity research analyst at swastika investmartHelix investment holdingsResearch analystHead of researchSmall medium enterprisesConcord biotechNon banking financial companyEquity research analystActive pharmaceutical ingredientOffer for saleSwastika investmartVentura securities

Share Market Highlights 07 August 2023: Sensex settles 232 points higher, Nifty closes at 19,597

Share Market Highlights 07 August 2023: Sensex settles 232 points higher, Nifty closes at 19,597
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

India generalUnited kingdomTamil naduSulawesi selatanUnited statesUttar pradeshMonte carloSaudi arabiaJammu and kashmirRichard loboVijay shekhar sharmaRelaxo footwearsTata chenUmm al qaiwainAurobindo pharmaPvbs psbs